Navigation Links
Roche Scientist Recognized for Excellence in Peptide Chemistry
Date:10/7/2009

sted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

About Roche Colorado

Roche Colorado Corporation, a subsidiary of the Roche Group, is a pharmaceutical manufacturing facility located in Boulder, Colorado. Roche Colorado has a workforce of about 300 employees, including chemists, engineers, and manufacturing personnel, who specialize in the production of therapeutic peptides and highly active compounds. The company has received particular acclaim for its work on the anti-HIV drug, Fuzeon® (enfuvirtide), a 36 amino acid peptide that was awarded the 2004 International Prix Galien as the world's most innovative new medicine. Roche Colorado's strong record of achievement in the synthetic peptide field earned it the Biotechnology Company of the Year award from the Colorado Bioscience Association. Learn more at www.rochecolorado.com/peptides.

    Contacts:  John Tayer                         Darien Wilson
               Public Affairs and Communications  Public Affairs
               303-938-6414                       973-562-2232
               John.tayer@roche.com               darien_e.wilson@roche.com

SOURCE Roche


'/>"/>
SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
3. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
4. Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
7. National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities
8. MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis
9. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
10. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
11. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  Ashion™ ... the rapidly evolving genomic medicine industry, announced ... medicine service using Syapse Precision Medicine Platform. ... Centers (PMCs) with partner regional healthcare systems, ... recommendations, genomic interpretation, education, and operational support. ...
(Date:6/2/2015)... June 2, 2015  Accuray Incorporated (Nasdaq: ARAY ... to present at the Goldman Sachs 36th Annual Global ... on Wednesday, June 10, 2015 at 4:00pm ... presentation will be available on the Investor Relations page ... webcast replay of the presentation will begin approximately one ...
(Date:6/2/2015)... MELBOURNE, Australia , June 2, 2015 /PRNewswire/ ... has successfully raised AUD$14.8 million to rapidly ... its lead Personal KinetiGraph™ (PKG™) mobile health ... Partners has contributed further capital in the ... funds, industry veterans, high net worth individuals ...
Breaking Medicine Technology:Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 2Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 3Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 2Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 3
... VIVUS, Inc. (NASDAQ: VVUS ) today ... accepted for review the company,s new drug application (NDA) for ... dysfunction (ED). The target date for the FDA to complete ... In previously announced results from the pivotal phase 3 trials, ...
... Sept. 1, 2011 Lung Cancer Alliance ... of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) ... on data from two clinical trials, both of which ... Xalkori targets the echinoderm microtubule-associated protein-like 4-anaplastic lymphoma ...
Cached Medicine Technology:VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction 2VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction 3New Drug Approved for Treatment of Non Small Cell Lung Cancer in Specific Patient Population 2
(Date:6/2/2015)... 03, 2015 BALTIMORE, Md. – ... a book about wellness after being diagnosed with lupus. ... that through lifestyle changes which enhance health, lupus and ... “ A Wellspring for Wellness ,” she offers a ... , This book provides an overview of some autoimmune ...
(Date:6/2/2015)... 02, 2015 Allred Dental, a dental office ... the months June-September, 2015 along with a $100 off with ... time only. , “Sometimes wisdom teeth can be impacted, meaning ... They can also only partially break through the gum, causing ... is easier in young people, as they do not have ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 The organic ... Cotton Market Report, an annual study conducted by Textile ... sustainable textile industry. The report, released today, encompasses extensive ... on a worldwide level and also takes the opportunity ... cotton market. , The last several years ...
(Date:6/2/2015)... Pleasant Prairie, WI (PRWEB) June 03, 2015 ... suited for regulated industries such as government, finance and ... any organization that wants reliable access control to enhance ... smart card keyboard requires the secondary authentication of a ... In addition to the smart-chipset card reader, the ...
(Date:6/2/2015)... Kan. (PRWEB) June 02, 2015 Concorde ... Bell as President and COO. Bell will manage day-to-day ... , “I’m looking forward to the opportunity to help ... students,” Bell said. “I joined Concorde in part due ... Institute that highlighted Concorde colleges in Memphis and Portland.” ...
Breaking Medicine News(10 mins):Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:Concorde Career Colleges Announces New President and COO 2
... National Basketball Association of the US has teamed up with ... kits on HIV/AIDS //to schools in seven provinces of China. ... the kits contain interactive HIV/AIDS learning materials for teachers and ... kit also contains a basketball and other sports equipment to ...
... care services provided to children with special health care ... be below their required need. //In addition, the poorer ... mental health care needs met. These are the two ... Harvard School of Public Health (HSPH) researchers, published in ...
... is generally referred to any factor that affects the physical, ... as we all know, has ramified into various sections of ... ,Although it has been argued that normal levels of ... many. During stress, an important hormone, cortisol, is secreted by ...
... long running disagreement over the funding of the brachytherapy machine ... travel to Christchurch for specialist treatment. ... cervical and other gynecological cancers and was proposed to be ... been ordered because the DHB wants other DHBs to share ...
... According to a study done by Ian Sheerin, lecturer ... of the patients were categorized as avoidable admissions//. The ... could be saved if the condition of the patients ... New Zealand Medical Journal. The largest proportion of avoidable ...
... the effects of alcohol during the drug action week. In ... part of drug action week. ,The role of ... and mental disabilities in children will be stressed during these ... disorders in Kimberley is as high as one in five. ...
Cached Medicine News:Health News:Health Care For Children With Special Needs Compromised 2Health News:Drug Action Week to Highlight Effects of Alcohol 2
IFA for the direct detection of Respiratory Syncytial Virus (RSV)...
BD Directigen RSV Test fast, easy and accurate, its truly STAT. And it will help your laboratory quickly and confidently support critical antiviral therapy recommendations....
Qualitative ELISA for the detection of rotavirus antigen....
Rapid membrane-based immunogold assay for the qualitative detection of rotavirus antigen in human fecal specimens; aids in the diagnosis of acute gastroenteritis caused by rotavirus infection....
Medicine Products: